Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ranitidine (HSDB 3925) is a non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 35.00 | |
10 mg | In stock | $ 45.00 | |
25 mg | In stock | $ 82.00 | |
50 mg | In stock | $ 108.00 | |
100 mg | In stock | $ 129.00 | |
200 mg | In stock | $ 233.00 | |
500 mg | In stock | $ 389.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 46.00 |
Description | Ranitidine (HSDB 3925) is a non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers. |
Targets&IC50 | H2 receptor:3.3 μM (IC50) |
Synonyms | HSDB 3925, Ranitidin |
Molecular Weight | 314.4 |
Formula | C13H22N4O3S |
CAS No. | 66357-35-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 57 mg/mL(181.3 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ranitidine 66357-35-5 GPCR/G Protein Immunology/Inflammation Metabolism Microbiology/Virology Neuroscience Antibacterial Histamine Receptor P450 HSDB3925 Bacterial CYPs HSDB 3925 secretion Ranitidin CYP2C9 CYP2C19 orally H2-receptor HSDB-3925 Cytochrome P450 Gastric inhibit Inhibitor inhibitor